Atyr Pharma Company Profile (NASDAQ:LIFE)

About Atyr Pharma

aTyr Pharma, Inc. is a clinical-stage biotherapeutics company. The Company is engaged in the discovery and clinical development of medicines for patients suffering from severe, rare diseases using its Physiocrine biology, a discovered set of physiological modulators. The Company focuses on the development of Physiocrine-based therapeutics for the treatment of rare diseases, including facioscapulohumeral muscular dystrophy (FSHD) and limb-girdle muscular dystrophy (LGMD) 2B. The Company is developing Resolaris, an intravenous protein therapeutic for the treatment of rare myopathies with an immune component (RMICs). The Company is investigating Resolaris in patients with LGMD2B. The Company is conducting approximately three open label trials in patients with early onset FSHD, in adult patients with FSHD or LGMD2B and a long-term extension study in adult patients with FSHD. The Company has not generated any revenues.

Industry, Sector and Symbol:

• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Life Sciences Tools & Services
• Exchange: NASDAQ
• Symbol: LIFE
• CUSIP: 53217V10

Key Metrics:

• Previous Close: $3.30
• 50 Day Moving Average: $3.1840
• 200 Day Moving Average: $3.4424
• 52-Week Range: $2.48 - $13.26
• Trailing P/E Ratio: N/A
• Foreward P/E Ratio: -1.36
• P/E Growth: 0.0000
• Market Cap: $78.58M
• Outstanding Shares: 23,718,000
• Beta: 3.26

Profitability:

• Return on Equity: -55.00%
• Return on Assets: -48.74%

Debt:

• Current Ratio: 6.17%
• Quick Ratio: 6.17%

Additional Links:

• Visit Atyr Pharma's Official Website
• View LIFE on Google Finance
• View LIFE on Yahoo Finance
• View LIFE's Company Profile on Reuters
• Search for Atyr Pharma Inc. on Google

Companies Related to Atyr Pharma:

• Nabriva Therapeutics AG - (NASDAQ:NBRV)
• Synthetic Biologics (NYSEMKT:SYN)
• Proteon Therapeutics (NASDAQ:PRTO)
• Sientra (NASDAQ:SIEN)
• BioDelivery Sciences International (NASDAQ:BDSI)
• Fortress Biotech (NASDAQ:FBIO)
• Axsome Therapeutics (NASDAQ:AXSM)
• Tetraphase Pharmaceuticals (NASDAQ:TTPH)
• Assembly Biosciences (NASDAQ:ASMB)
• Trovagene (NASDAQ:TROV)

Earnings

Earnings History for Atyr Pharma (NASDAQ:LIFE)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call	Details
11/8/2016
8/10/2016	Q216	($0.71)	($0.65)			View	N/A
5/11/2016	Q1	($0.70)	($0.68)			View	N/A
3/30/2016	Q4	($0.52)	($0.70)			View	N/A
11/10/2015	Q3	($0.48)	($0.48)			View	N/A
8/12/2015	Q215	($0.53)	($0.74)			View	N/A
6/18/2015	Q115	($0.41)	($9.39)			View	N/A
11/5/2013	Q313	$0.97	$1.02	$926.10 million	$936.00 million	View	N/A
7/31/2013	Q2 2013	$0.96	$0.72	$952.06 million	$944.00 million	View	N/A
5/2/2013	Q1 2013	$1.04	$1.07	$958.56 million	$963.00 million	View	N/A
2/4/2013	Q4 2012	$1.11	$1.11	$988.85 million	$998.90 million	View	N/A
11/1/2012	Q312	$0.89	$0.92	$907.91 million	$911.00 million	View	N/A
7/31/2012		$0.97	$0.96			View	N/A
2/7/2012		$1.04	$1.06			View	N/A
10/25/2011		$0.88	$0.94			View	N/A
7/28/2011		$0.95	$0.89			View	N/A
4/26/2011		$0.85	$0.85			View	N/A
2/3/2011		$0.87	$0.90			View	N/A

(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Atyr Pharma (NASDAQ:LIFE)

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	1	($0.70)	($0.70)	($0.70)
Q2 2016	1	($0.68)	($0.68)	($0.68)
Q3 2016	1	($0.66)	($0.66)	($0.66)
Q4 2016	1	($0.66)	($0.66)	($0.66)

(Data provided by Zacks Investment Research)

Dividends

Dividend History for Atyr Pharma (NASDAQ:LIFE)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Atyr Pharma (NASDAQ:LIFE)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Details
5/11/2016	Grove Matsuoka	Insider	Buy	12,412	$3.04	$37,732.48
4/14/2016	Paul Schimmel	Director	Buy	66,219	$4.18	$276,795.42
4/13/2016	Paul Schimmel	Director	Buy	9,835	$3.85	$37,864.75
4/12/2016	Paul Schimmel	Director	Buy	9,127	$3.71	$33,861.17
4/11/2016	Paul Schimmel	Director	Buy	32,659	$3.57	$116,592.63
4/8/2016	Paul Schimmel	Director	Buy	85,000	$3.22	$273,700.00
4/7/2016	Paul Schimmel	Director	Buy	40,000	$3.19	$127,600.00
4/6/2016	Paul Schimmel	Director	Buy	25,000	$3.20	$80,000.00
4/5/2016	John Mendlein	CEO	Buy	2,500	$3.55	$8,875.00
4/5/2016	Paul Schimmel	Director	Buy	25,000	$3.52	$88,000.00
5/12/2015	James E Flynn	Insider	Buy	50,000	$14.00	$700,000.00
5/12/2015	Sofinnova Venture Partners Ix,	Major Shareholder	Buy	320,000	$14.00	$4,480,000.00
5/29/2013	David C Uprichard	Director	Sell	2,010	$74.04	$148,820.40
5/28/2013	John A Cottingham	Insider	Sell	60,000	$74.03	$4,441,800.00

(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Atyr Pharma (NASDAQ:LIFE)

Date	Headline
	Stocks to Must have in Portfolio: General Electric (GE), aTyr Pharma (LIFE), Celldex Therapeutics (CLDX) - Street Wise Report (press release) (blog) (NASDAQ:LIFE) streetwisereport.com - September 22 at 5:42 PM
	aTyr Pharma Appoints Industry Veteran in Novel Biology Biologics, David J. King, PhD, as Senior Vice President ... - Yahoo Finance (NASDAQ:LIFE) finance.yahoo.com - September 22 at 5:42 PM
	aTyr Pharma : Appoints Industry Veteran in Novel Biology Biologics, David J. King, PhD, as Senior Vice President, Research (NASDAQ:LIFE) www.4-traders.com - September 22 at 9:07 AM
	aTyr Pharma Appoints Industry Veteran in Novel Biology Biologics, David J. King, PhD, as Senior Vice President, Research (NASDAQ:LIFE) www.publicnow.com - September 22 at 9:07 AM
	Earnings Analysis & Update for aTyr Pharma Inc (NASDAQ:LIFE)? - Frisco Fastball (NASDAQ:LIFE) friscofastball.com - September 21 at 4:09 PM
	Atyr Pharma Inc. (LIFE) Trading 2.3% Higher - NewsDen (NASDAQ:LIFE) newsden.net - September 15 at 9:17 AM
	Analysts Take the Wheel on aTyr Pharma Inc (NASDAQ:LIFE) Shares and Where They Might Be Headed - Frisco Fastball (NASDAQ:LIFE) friscofastball.com - September 9 at 5:42 PM
	HC Stocks Reports Analysis - aTyr Pharma Inc (NASDAQ:LIFE), Keryx Biopharmaceuticals (NASDAQ:KERX) - share market updates (press release) (NASDAQ:LIFE) sharemarketupdates.com - August 30 at 5:56 PM
	New Market Research Report: aTyr Pharma, Inc. (LIFE) - Financial and Strategic SWOT Analysis Review (NASDAQ:LIFE) www.live-pr.com - August 26 at 8:57 AM
	ATYR PHARMA INC Financials (NASDAQ:LIFE) finance.yahoo.com - August 19 at 5:54 PM
	Institutions Have Decreased Their Ownership of aTyr Pharma Inc. (NASDAQ:LIFE) - Post News (NASDAQ:LIFE) www.kentuckypostnews.com - August 18 at 5:58 PM
	MNK Opens Wallet, CYNA Awaits Parkinson's Drug Data, 3rd Time's A Charm For HRTX (NASDAQ:LIFE) www.rttnews.com - August 11 at 9:02 AM
	aTyr Pharma Inc. (LIFE) (NASDAQ:LIFE) finance.yahoo.com - August 10 at 6:17 PM
	aTyr Pharma Announces Second Quarter 2016 Operating Results (NASDAQ:LIFE) www.prnewswire.com - August 10 at 6:17 PM
	Atyr Pharma reports 2Q loss (NASDAQ:LIFE) sg.finance.yahoo.com - August 10 at 6:17 PM
	4:16 pm aTyr Pharma reports 2Q16 net loss per share of ($0.65) vs. ($0.74) year ago; no revenue (NASDAQ:LIFE) finance.yahoo.com - August 10 at 6:17 PM
	ATYR PHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:LIFE) biz.yahoo.com - August 10 at 6:17 PM
	Market Review – Manufacturing Stocks Gainers, Losers (NASDAQ:LIFE) www.fxpips.com - August 2 at 10:46 AM
	aTyr Pharma Technicals Signal Stock Is Set To Deliver (NASDAQ:LIFE) www.investing.com - July 31 at 10:07 AM
	HC Stocks Judgment: aTyr Pharma Inc (NASDAQ:LIFE), Keryx Biopharmaceuticals (NASDAQ:KERX) - share market updates (press release) (NASDAQ:LIFE) sharemarketupdates.com - July 26 at 6:11 PM
	Checking in on Stock Volatility for: aTyr Pharma Inc. (NASDAQ:LIFE) - Engelwood Daily (NASDAQ:LIFE) www.engelwooddaily.com - July 23 at 9:55 AM
	Analysts Reviewing Stocks: InspireMD, Inc. (NYSEMKT:NSPR) , aTyr Pharma, Inc. (NASDAQ:LIFE) - Street Updates (NASDAQ:LIFE) www.streetupdates.com - July 23 at 9:55 AM
	Stock Moving Lower for the Month; Investor Update on aTyr Pharma Inc. (NASDAQ:LIFE) - Engelwood Daily (NASDAQ:LIFE) www.engelwooddaily.com - July 20 at 10:28 PM
	Heightened Volatility Spotted on Shares of: aTyr Pharma Inc. (NASDAQ:LIFE) - Engelwood Daily (NASDAQ:LIFE) www.engelwooddaily.com - July 20 at 10:28 PM
	aTyr Pharma Inc's Trend Up, Especially After Today's Strong Session - Press Telegraph (NASDAQ:LIFE) presstelegraph.com - July 20 at 10:28 PM
	Bach Pharma Appoints Kelly Blackburn as Chief Executive Officer (NASDAQ:LIFE) www.bizjournals.com - July 15 at 5:01 PM
	Atyr Pharma Incorporated (NASDAQ:LIFE) Sellers Covered 6.41% of Their Shorts - Press Telegraph (NASDAQ:LIFE) presstelegraph.com - July 15 at 10:03 AM
	Stock Volatility Focus for: aTyr Pharma Inc. (NASDAQ:LIFE) - Engelwood Daily (NASDAQ:LIFE) www.engelwooddaily.com - July 12 at 6:11 PM
	How Many aTyr Pharma Inc (NASDAQ:LIFE)'s Analysts Are Bullish? - Consumer Eagle (NASDAQ:LIFE) www.consumereagle.com - July 12 at 6:11 PM
	HC Stocks Reports Analysis: aTyr Pharma Inc (NASDAQ:LIFE), Keryx Biopharmaceuticals (NASDAQ:KERX) - share market updates (press release) (NASDAQ:LIFE) sharemarketupdates.com - July 12 at 6:11 PM
	Atyr Pharma Incorporated (NASDAQ:LIFE) Shorts Decreased by 6.41% After Short Covering - Engelwood Daily (NASDAQ:LIFE) www.engelwooddaily.com - July 6 at 6:10 PM
	Were Analysts Bearish aTyr Pharma Inc (NASDAQ:LIFE) This Week? - Press Telegraph (NASDAQ:LIFE) presstelegraph.com - July 5 at 10:33 AM
	What Next for aTyr Pharma Inc Stock After Today's Huge Decline? - Press Telegraph (NASDAQ:LIFE) presstelegraph.com - June 29 at 5:49 PM
	Shares Up in Session: aTyr Pharma Inc. (NASDAQ:LIFE) - Telanagana Press (NASDAQ:LIFE) telanaganapress.com - June 29 at 5:49 PM
	Watching Stock Volatility for: aTyr Pharma Inc. (NASDAQ:LIFE) - Engelwood Daily (NASDAQ:LIFE) www.engelwooddaily.com - June 29 at 5:49 PM
	Atyr Pharma Incorporated (NASDAQ:LIFE) Short Interest Decreased By 6.41% - Press Telegraph (NASDAQ:LIFE) presstelegraph.com - June 28 at 10:49 AM
	Global Tuberculosis Pipeline 2016 Market Report on 64 Companies - PR Newswire (press release) (NASDAQ:LIFE) www.prnewswire.com - June 17 at 8:43 AM
	ATYR PHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:LIFE) biz.yahoo.com - June 16 at 5:17 PM
	aTyr Pharma, Inc. :LIFE-US: Earnings Analysis: Q1, 2016 By the Numbers : June 10, 2016 (NASDAQ:LIFE) www.capitalcube.com - June 10 at 5:01 PM
	ATYR PHARMA INC. (NASDAQ:LIFE) Financial Condition Compared to S&P 500 - CML News (NASDAQ:LIFE) news.cmlviz.com - June 8 at 6:16 PM
	Atyr Pharma Incorporated (NASDAQ:LIFE) Shorted Shares Increased By 7.31% - HNN (NASDAQ:LIFE) hintsnewsnetwork.com - June 3 at 6:21 PM
	aTyr Pharma Inc (NASDAQ:LIFE) Stock Update & Estimates - Stock Tick Tock (NASDAQ:LIFE) www.stockticktock.com - June 3 at 6:21 PM
	aTyr Pharma to Present at Jefferies 2016 Healthcare Conference - Stockhouse (NASDAQ:LIFE) www.stockhouse.com - June 3 at 8:43 AM
	aTyr Pharma Inc (NASDAQ:LIFE) Quarterly EPS Estimate At $-0.74 - Investor Newswire (NASDAQ:LIFE) www.investornewswire.com - June 2 at 6:15 PM
	ATYR PHARMA INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:LIFE) biz.yahoo.com - May 26 at 4:01 PM
	Fast Moving Stocks: aTyr Pharma (NASDAQ:LIFE), Public Service Enterprise Group (NYSE:PEG), ShoreTel, (NASDAQ ... - KC Register (NASDAQ:LIFE) www.kcregister.com - May 23 at 12:52 PM
	aTyr Pharma Inc (NASDAQ:LIFE) One-Year Price Target At $9.00 - Stocks Daily (NASDAQ:LIFE) www.stocksdaily.net - May 23 at 12:52 PM
	aTyr Pharma Inc (NASDAQ:LIFE) Comprehensive Income At $-0.171 - Stocks Daily (NASDAQ:LIFE) www.stocksdaily.net - May 18 at 12:35 AM
	aTyr Pharma Inc (NASDAQ:LIFE) One-Year Price Projection At $8 - Investor Newswire (NASDAQ:LIFE) www.investornewswire.com - May 16 at 1:00 PM
	aTyr Pharma, Inc. (NASDAQ:LIFE) Is Trading Down – Insider Trading Activity (NASDAQ:LIFE) www.fidaily.com - May 13 at 1:13 AM

Social

Atyr Pharma (NASDAQ:LIFE) Chart for Monday, September, 26, 2016